4//SEC Filing
Oliver Tracie 4
Accession 0001209191-23-002121
CIK 0000879407other
Filed
Jan 4, 7:00 PM ET
Accepted
Jan 5, 7:21 PM ET
Size
5.3 KB
Accession
0001209191-23-002121
Insider Transaction Report
Form 4
Oliver Tracie
Chief Commercial Officer
Transactions
- Award
Common Stock
2023-01-04+500→ 70,500 total
Footnotes (2)
- [F1]Represents shares underlying a restricted stock unit, which shares will vest in four equal annual installments, with a commencement date of 1/4/23.
- [F2]Includes previously reported shares of common stock underlying Restricted Stock Units granted to the Reporting person which are subject to certain vesting conditions.
Documents
Issuer
ARROWHEAD PHARMACEUTICALS, INC.
CIK 0000879407
Entity typeother
Related Parties
1- filerCIK 0001935706
Filing Metadata
- Form type
- 4
- Filed
- Jan 4, 7:00 PM ET
- Accepted
- Jan 5, 7:21 PM ET
- Size
- 5.3 KB